BioInvent International AB (BINV.ST)

BINV.ST on Stockholm Stock Exchange

2.90SEK
29 Aug 2014
Price Change (% chg)

0.01kr (+0.35%)
Prev Close
2.89kr
Open
2.94kr
Day's High
2.94kr
Day's Low
2.87kr
Volume
89,836
Avg. Vol
171,933
52-wk High
4.64kr
52-wk Low
2.07kr

BINV.ST

Chart for BINV.ST

About

BioInvent International AB (BioInvent) is a Sweden-based biopharmaceutical company. The Company is engaged in the research and development of antibody-based drugs for the treatment of diseases, such as thrombosis, cancer and acute coronary artery disease. Its product range includes human antibodies, such as TB-402, TB-403,... (more)

Overall

Beta: 0.67
Market Cap (Mil.): kr327.09
Shares Outstanding (Mil.): 112.79
Dividend: --
Yield (%): --

Financials

  BINV.ST Industry Sector
P/E (TTM): -- 153.62 33.23
EPS (TTM): -0.23 -- --
ROI: -37.34 -3.27 17.21
ROE: -37.34 -7.88 18.01
Search Stocks

BRIEF-Bioinvent posts Q2 net profit

July 24 - Bioinvent : * Q2 net sales 32 (12) msek * Q2 net profit 3.7 (-9.4) msek Link to press release: http://mb.cision.com/Main/583/9620296/269435.pdf

24 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics (Premium)
$25.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks